Chompu-Inwai Papimon, Simprasert Sophon, Chuveera Patchanee, Nirunsittirat Areerat, Sastraruji Thanapat, Srisuwan Tanida
Division of Pediatric Dentistry, Department of Orthodontics and Pediatric Dentistry, Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand.
Former postgraduate student in pediatric dentistry, Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand.
Anesth Prog. 2018 Fall;65(3):156-161. doi: 10.2344/anpr-65-02-08.
To compare the success of perceived pulpal anesthesia between groups using nitrous oxide/oxygen (NO/O) and oxygen (O) in children premedicated with ibuprofen with symptomatic irreversible pulpitis permanent teeth. Thirty-three children (mean age 10.4 ± 1.9 years) with 33 symptomatic irreversible pulpitis permanent teeth were included in this preliminary study. All children were premedicated with ibuprofen and randomly assigned to receive either NO/O (17 participants) or O (16 participants). Four percent articaine with epinephrine 1:100,000 was administered, and vital pulp therapy was performed. Children used the Wong-Baker FACES Pain Rating Scale (WBFPS) to report their pain at baseline as well as during carious dentin removal, pulpal exposure, and pulpal tissue removal steps. The success was determined when the reported WBFPS score was ≤4. The chi-square test was used to compare the success between both groups. The success of pulpal anesthesia was 71% (12/17) and 19% (3/16) in the NO/O and O groups, respectively. The success in the NO/O group was 52% higher than that in the O group (confidence interval = 22.9% to 80.7%; significant difference p = .003). From the result of this preliminary study, NO/O significantly increased the success of perceived pulpal anesthesia in children premedicated with ibuprofen with symptomatic irreversible pulpitis permanent teeth. However, further study with a larger sample is required to confirm this result.
比较在使用一氧化二氮/氧气(NO/O)和氧气(O)的情况下,对患有症状性不可逆牙髓炎恒牙且已用布洛芬进行术前用药的儿童进行牙髓麻醉的成功率。本初步研究纳入了33名患有33颗症状性不可逆牙髓炎恒牙的儿童(平均年龄10.4±1.9岁)。所有儿童均用布洛芬进行术前用药,并随机分配接受NO/O(17名参与者)或O(16名参与者)。给予含1:100,000肾上腺素的4%阿替卡因,并进行牙髓活力治疗。儿童使用面部表情疼痛评分量表(WBFPS)在基线以及龋坏牙本质去除、牙髓暴露和牙髓组织去除步骤期间报告他们的疼痛。当报告的WBFPS评分≤4时确定为成功。使用卡方检验比较两组之间的成功率。NO/O组和O组的牙髓麻醉成功率分别为71%(12/17)和19%(3/16)。NO/O组的成功率比O组高52%(置信区间=22.9%至80.7%;显著差异p=.003)。从这项初步研究的结果来看,NO/O显著提高了对患有症状性不可逆牙髓炎恒牙且已用布洛芬进行术前用药的儿童进行牙髓麻醉的成功率。然而,需要进一步进行更大样本的研究来证实这一结果。